Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer | NEJM
La FDA approuve Lonsurf plus bevacizumab pour le traitement du cancer colorectal métastatique
Adding Avastin to Lonsurf Improved Outcomes in Pretreated Colorectal Cancer
NEJM on X: "This editorial describes the science behind a clinical trial performed by Prager and colleagues: a test of trifluridine–tipiracil and bevacizumab to treat patients with refractory metastatic colorectal cancer. https://t.co/Y1QlV28qsr" /
LONSURF® (trifluridine and tipiracil) tablets | Previously Treated mCRC Treatment | TAS-102 Efficacy
4. Cancer colorectal métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive
Benefits & Risks of Treatment | Metastatic Colorectal Cancer (mCRC)| Avastin® (bevacizumab)
Servier : AMM européenne pour LONSURF en association au bevacizumab dans le cancer colorectal métastatique réfractaire | MyPharma Editions
How to Take LONSURF® (trifluridine and tipiracil) tablets | Helpful Dosage Reminders
Third-Line Treatment for Metastatic Colorectal Cancer | LONSURF® (trifluridine and tipiracil) tablets
La trifluridine plus le tipiracil et le bévacizumab est une nouvelle norme de soins pour le cancer colorectal métastatique réfractaire
Precision treatment in colorectal cancer: Now and the future - Yau - 2019 - JGH Open - Wiley Online Library
La trifluridine plus le tipiracil et le bévacizumab est une nouvelle norme de soins pour le cancer colorectal métastatique réfractaire
How does chemo fit into my treatment plan? - Colontown University
Lonsurf® Treatment for Colorectal Cancer - CancerConnect
Trifluridine/Tipiracil in Previously Treated Metastatic Colorectal Cancer - The ASCO Post
TAS-102 plus bevacizumab: a new standard for metastatic colorectal cancer? - The Lancet Oncology
NCCN® Guidelines for Metastatic Colon Cancer Treatment
Current Oncology | Free Full-Text | A Systematic Review and Meta-Analysis of Trifluridine/Tipiracil plus Bevacizumab for the Treatment of Metastatic Colorectal Cancer: Evidence from Real-World Series
Lonsurf (Trifluridine plus Tipiracil): A New Oral Treatment Approved for Patients with Metastatic Colorectal Cancer
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer | NEJM
Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in Australia - Price - 2020 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
